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Abstract
Foreign-born persons in the United States seeking to adjust their status to permanent resident must 
undergo screening for tuberculosis (TB) disease. Screening is performed by civil surgeons (CS) 
following technical instructions by the Centers for Disease Control and Prevention. From 2011 to 
2012, 1,369 practicing CS in California, Texas, and New England were surveyed to investigate 
adherence to the instructions. A descriptive analysis was conducted on 907 (66 %) respondents. Of 
907 respondents, 739 (83 %) had read the instructions and 565 (63 %) understood that a chest 
radiograph is required for status adjustors with TB symptoms; however, only 326 (36 %) knew that 
a chest radiograph is required for immunosuppressed status adjustors. When suspecting TB 
disease, 105 (12 %) would neither report nor refer status adjustors to the health department; 91 
(10 %) would neither start treatment nor refer for TB infection. Most CS followed aspects of the 
technical instructions; however, educational opportunities are warranted to ensure positive patient 
outcomes.
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Introduction
In 2012, 9,951 cases of tuberculosis (TB) were reported in the United States, 63 % of which 
occurred in the foreignborn population [1]. Previous studies of Mycobacterium tuberculosis 
complex genotypes indicate that the majority of these cases are caused by reactivation of 
latent tuberculosis infection (LTBI), probably the result of exposure prior to arrival in the 
United States [2, 3]. Detecting and treating TB disease and LTBI in persons born outside of 
the United States has been designated as a high-priority strategy for TB control and 
elimination efforts [4–6].
Applicants for permanent residence in the United States, e.g. immigrants and refugees, are 
required to undergo pre-immigration TB screening overseas. The application process 
overseas includes screening by panel physicians, appointed by the United States embassy or 
consulate, prior to arrival. Previous studies have shown overseas TB screening to be an 
effective, high-yield intervention for detecting TB disease and LTBI in this population [7, 8]. 
“Status adjustment” is the process by which persons already living legally in the United 
States with temporary visas, e.g. student and temporary worker visas, can apply for 
permanent residence. The status adjustment process includes a medical assessment 
performed by a civil surgeon (CS), a physician who has applied for this designation and 
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been selected by the U.S. Citizenship and Immigration Services (USCIS). CS must have a 
minimum of 4 years of professional experience (not including internships and residencies) 
and maintain a current medical license. To perform status adjustment assessments, CS 
follow the Technical Instructions for Medical Examination of Aliens, requirements and 
recommendations published by the Centers for Disease Control and Prevention (CDC) in 
1991 and revised in 2008 [9]; however, limited training has been provided. Furthermore, a 
1997 assessment of CS adherence to the technical instructions revealed problems in 
screening practices [10].
The technical instructions require that status adjustors 2 years of age and older be tested for 
LTBI using a tuberculin skin test (TST) or interferon-gamma release assay (IGRA); status 
adjustors less than 2 years of age must be tested if there is evidence of contact with a person 
who has TB. Those with a TST induration ≥ 5 mm or a positive IGRA test result should 
have a chest radiograph (CXR). Status adjustors who are immunosuppressed or have 
symptoms suggestive of TB should have a CXR regardless of the TST or IGRA result. 
Status adjustors with abnormal CXR suggestive of active or inactive TB should be referred 
to their local health department for evaluation before being medically cleared for status 
adjustment. According to the technical instructions, status adjustors who have no evidence 
of TB disease, have a TST induration ≥ 10 mm (≥ 5 mm for contacts and immunosuppressed 
persons), and are recent arrivers (within 5 years) should be referred to the health department 
for possible LTBI treatment.
In fiscal year 2012, USCIS received almost 800,000 applications for adjustment of status 
[11]. Few studies have investigated the prevalence of TB disease and LTBI among status 
adjustors; however, one study in Denver in 1987 found that greater than 40 % of status 
adjustors had TST results indicative of LTBI [12].
The objective of this investigation was to gather information on the medical training, 
experience, and type of practice among CS in two states and one region of the United States 
and to assess whether the TB screening procedures in each state or region are consistent with 
those indicated in the Technical Instructions for Medical Examination of Aliens.
Methods
From July 2011 to July 2012, eight state TB control programs conducted a survey of CS in 
their states. Participating states were selected through existing collaborations; however, all 
had a percentage of TB cases among foreignborn persons higher than the national average. 
Surveys were mailed to all CS in California, Texas, and six New England states 
(Connecticut, Maine, Massachusetts, New Hampshire, Rhode Island, and Vermont) using 
contact information obtained from the USCIS website. Approximately 4–8 weeks following 
the initial mailing, a second mailing was sent to non-responders. The remaining non-
responders were contacted by telephone and fax. The six-page survey consisted of 25 
questions, primarily multiple choice, on the characteristics of the respondent’s training and 
practice, their TB screening and medical follow-up practices, and a scenario-based question. 
Two additional questions, including a second scenario-based question, were included in the 
surveys sent to CS in California and Texas.
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Completed surveys were analyzed using SAS v. 9.3. Respondents who indicated they were 
no longer in practice as a CS were excluded from analysis. Completed surveys that did not 
include respondent identification numbers were also excluded to avoid duplication. 
Pearson’s Chi-square and Fisher’s exact tests were used to analyze categorical variables and 
two sample and multi-sample (Brown-Mood) median tests for difference in location were 
used to analyze continuous variables. A significance level of P <0.05 was used in analyses.
As the purpose of this survey was to gather information with the intent of informing and 
evaluating public health practice, the CDC Human Research Protections Office determined 
that this project was routine public health evaluation and not human subjects research.
Results
From July 2011 to July 2012, surveys were mailed to 918 practicing CS in California, 308 in 
Texas, and 143 in the New England region. A total of 907 CS responded for an overall 
response rate of 66 %: 584 (64 %) CS in California returned surveys, 203 (66 %) CS in 
Texas, and 120 (84 %) CS in the New England region. Table 1 shows demographic 
characteristics of respondents by region. The majority were in private, independent practice, 
ranging from 59 % in New England to 98 % in Texas. The median number of years in 
practice as CS was 10 with an interquartile range of 4–19 years.
Ninety-five percent of respondents received at least some training as residents or fellows in a 
primary care field. Approximately half of respondents from California and Texas received 
their medical education outside of the United States (54 and 50 %, respectively), compared 
to 28 % in New England. Although a majority of CS in each region reported reading the 
2008 technical instructions, 149 out of 888 respondents (17 %) did not or could not 
remember reading them. In the 3 years prior to survey completion, 135 (15 %) respondents 
recalled diagnosing a total of 236 cases of TB disease among status adjustors, with the 
greatest percentage diagnosed in New England.
Almost all CS respondents used TST or IGRA to initially screen status adjustors for TB; 
CXR was used as the sole screening test among 8 of 904 CS (1 %), overall (Table 2). 
However, 14 % of respondents in California and Texas used CXR as the sole screening test 
when status adjustors were vaccinated with Bacille Calmette-Guerin (BCG). When asked 
about the TST cutoff for the purposes of the status adjustment examination, only 64 % of CS 
in California and Texas chose the correct cut-off of ≥ 5 mm (New England respondents were 
not asked this question). Despite this, when respondents were asked about a TST with 7 mm 
induration in a case scenario (a healthy, BCG-vaccinated 19-year old status adjustor), 80 % 
correctly responded that this TST result should prompt having a CXR done.
The vast majority of respondents would obtain a CXR for all status adjustors with a positive 
TST or IGRA result as required by the technical instructions. However, just 565 (63 %) of 
respondents would obtain a CXR, per the technical instructions, for status adjustors with 
symptoms suggestive of TB who should be evaluated regardless of the TST or IGRA result, 
and only 326 (36 %) would obtain one for status adjustors who are immunosuppressed.
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Table 3 details CS responses about LTBI and possible TB disease. Overall, 801 (90 %) 
respondents would start treatment or refer for treatment upon diagnosing LTBI. If TB 
disease were suspected, a similar number, 775 (88 %), would report or refer status adjustors 
to the health department. Respondents in California and Texas were also presented with a 
case scenario regarding a status adjustor with a positive TST result and an abnormal CXR 
consistent with healed TB. Just under half, 359 respondents (46 %), selected the correct next 
step (per the technical instructions) of referral to the health department.
Differences between CS characteristics and their TB screening and medical follow-up 
practices were assessed in Table 4. Differences by region were observed. In the 30 days 
preceding the survey, CS respondents in Texas and New England performed more status 
adjustor evaluations than respondents in California (median 9 and 8 respectively, vs. 5; P <.
01; Brown Mood median test). Respondents in California and Texas more frequently 
referred status adjustors with suspected TB disease to the health department (90 % in 
California, 87 % in Texas, and 79 % in New England, P <.01, Pearson’s Chi square).
Differences among CS were also found by practice type and volume of status adjustors 
examined (Table 4). CS respondents in private, independent practice evaluated more status 
adjustors in the 30 days preceding the survey than respondents who practiced in community 
health centers (CHCs) (6 vs. 1, P <.01). Private practitioners were also more likely to read 
the technical instructions (85 vs. 73 %, P <.01) and to respond correctly in the TST case 
scenario (84 vs. 57 %, P <.01). However, respondents who practice in CHCs were more 
likely to either start treatment for LTBI or refer status adjustors to other providers for LTBI 
treatment (95 vs. 89 %, P = .04, Fisher’s exact). Independent of practice type, CS who 
evaluated more than the median number of status adjustors in the past 30 days were more 
likely to read the technical instructions (88 vs. 81 %, P <.01) and to respond correctly to the 
TST case scenario (88 vs. 77 %, P <.01).
Finally, CS respondents were evaluated for associations between training and experience and 
TB screening and medical follow up practices (Table 5). Respondents who had been in 
practice as a CS for more than 9 years evaluated more status adjustors in the 30 days 
preceding the survey than those with fewer years in practice (6 vs. 5, P <.01) but were less 
likely to read the technical instructions (81 vs. 87 %, P = .02). Respondents were also 
compared by the country in which they attended medical school. CS who attended medical 
school in the United States were less likely to respond correctly in the TST case scenario (77 
vs. 84 %, P = .01) and less likely to report or refer status adjustors with suspected TB 
disease to the health department (86 vs. 91 %, P = .01). No significant differences were 
found between CS who received training in a primary care field and those who did not (data 
not shown).
Discussion
In this evaluation of self-reported TB medical examination procedures, CS in New England, 
Texas, and California were found to follow CDC’s technical instructions in important areas; 
however, there are several areas where additional training or monitoring might improve 
adherence.
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The vast majority of survey respondents used appropriate TB screening tests. However, 
when asked specifically about screening BCG-vaccinated status adjustors, 18 % of 
California CS and 20 % of Texas CS did not follow the technical instructions’ requirement 
to screen these adjustors with a TST or IGRA. In addition, over a third of CS in these 
regions did not select the correct TST cut-off for obtaining a CXR for a status adjustment 
examination. On the other hand, after interpreting a test result as positive, almost all CS 
obtained a CXR as required. In 2008, the CDC issued a new version of the technical 
instructions (replacing the 1991 version). Although the updated instructions also require a 
CXR for status adjustors who have symptoms suggestive of TB or are immunosuppressed, 
more than half of respondents did not obtain CXRs for immunosuppressed status adjustors 
and more than a third did not obtain them for status adjustors with symptoms suggestive of 
TB, regardless of TST or IGRA result.
If a CXR indicates abnormal findings indicative of either TB disease or old healed TB, the 
technical instructions require CS to refer status adjustors to the health department for further 
evaluation. Health departments and their consulting physicians may have experience with 
the potential complications inherent in TB treatment, drug-resistant TB, and the need for 
directly observed therapy, therefore increasing the likelihood of a successful treatment 
course [13]. Approximately 90 % of CS in California and Texas and 80 % of CS in New 
England adhere to this requirement and either report or refer status adjustors with suspected 
TB disease to their local or state health department. Similar percentages of CS also follow 
the technical instructions’ recommendation to refer status adjustors diagnosed with LTBI to 
be evaluated for treatment. Additional training to reach those CS that do not refer could 
improve the usefulness of TB screening by increasing the proportion of patients initiating 
early treatment, thereby possibly preventing progression to TB disease and future TB 
transmission.
Few studies have previously investigated CS performance or practices. An analysis of TB 
screening outcomes for status adjustment medical exams, as reported on USCIS forms, 
performed in 1997 and 1998 in San Diego, San Francisco, New York, and Massachusetts 
also found moderate adherence among CS to the CDC’s technical instructions: 74 % (4,121 
of 5,570) of adjustors were appropriately screened [10]. Of those who were not evaluated 
appropriately, 1,172 (21 %, range 8–52 %) were referred for a CXR with no prior 
administration of a TST. This percentage is considerably higher than the 1 % of our survey 
respondents who reported screening in this manner. It is possible that this difference could 
reflect a self-reporting bias in our results: CS may have indicated their ideal rather than their 
actual practices when completing the survey. Similar to the results reported here, that study 
also showed regional variation in CS adherence, suggesting that future training and 
assessments should be tailored to meet region- or state-specific needs.
Another study of CS screening in Denver in 1987 and 1988 investigated the yield of TB 
screening among status adjustors for both TB and LTBI. Of the 6,520 patients reviewed, four 
new TB cases were found and 42 % had TST results indicative of LTBI [12]. Our evaluation 
did not quantify the number of LTBI diagnoses made; however, the respondents estimated 
that in the past 3 years they had diagnosed more than 200 cases of TB disease. This estimate 
suggests that CS screening may be an effective intervention for reducing the burden of TB 
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among foreign-born persons. Mathematical models of future TB trends underscore the 
importance of increased TB screening and treatment among foreign-born persons in order to 
achieve TB elimination [14, 15]. Current domestic recommendations advocate for testing for 
LTBI infection among immigrants from high prevalence countries who have arrived in the 
last 5 years [16]; however, foreign-born persons infected with TB continue to be at increased 
risk for progression to disease, even after several years of living in the United States [6, 17–
19]. CS screening presents an important opportunity to prevent these cases by finding and 
treating LTBI that might otherwise be missed. Seventy-six percent of our respondents said 
they referred status adjustors for LTBI treatment; however, the number of adjustors referred 
as well as the rates of treatment initiation and completion are unknown. Improving 
communication between CS and the providers and health departments that are working to 
ensure completion of LTBI treatment, could capitalize on this opportunity.
Additional training and resources for CS TB screening offered by state health departments, 
USCIS, and CDC may help reduce the TB burden in the United States. Because gaps in CS 
knowledge and adherence appear to vary by region, practice type, volume of status adjustors 
seen, location of medical training, and years as a CS, trainings tailored to specific sub-
groups of practitioners might be beneficial. Areas of focus should include proper 
interpretation of TSTs for the purpose of status adjustment and referral of high risk status 
adjustors (i.e., immunosuppressed and symptomatic) for CXRs, regardless of the TB test 
result. Emphasis should continue to be placed on reporting and linkages to care between the 
CS diagnosing status adjustors with TB disease or infection and the state or local health 
departments who have the expertise in TB treatment and case management. Changes to the 
technical instructions should be clearly communicated to CS to ensure they are aware of 
updates and are implementing them in their practice.
Additionally, periodic assessments of adherence to and results of CS screening could allow 
for more consistent recognition of training gaps and improved resource allocation. 
Assessments may indicate the need for additional incentives or disincentives to improve CS 
adherence. Increased communication and data sharing between USCIS and state and local 
health departments to track TB outcomes might assist in highlighting important areas for 
improvement in CS screening.
The major limitation of this evaluation is its reliance on self-reported survey data. CS 
responses may be biased to reflect desired practices or unreliable because of poor recall. If 
so, the results described might be an overestimation of how well the technical instructions 
are followed. Additionally, moderate response rates may have resulted in biased results. For 
example, CS who were more likely to read and follow the instructions for status adjustment 
examinations might also be more likely to complete and return the survey. If present, this 
pattern would also tend to overestimate how well the technical instructions are followed. 
Finally, surveys administered in the six New England states were pooled and analyzed in 
aggregate which might have masked differences within this region.
These data reflect the first investigation in the past decade of CS characteristics and their TB 
screening of status adjustors. Responses indicate areas for training that could improve the 
ability of CS screening to diagnose LTBI and TB disease, ensure referral to public health 
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programs for appropriate treatment and case management, and possibly prevent future 
transmission of disease.
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Table 1
Characteristics of civil surgeons in California, Texas, and New England, 2011–2012
Characteristica California Texas New England Total
Practice location
  Private, independent practice 489 (86.7) 194 (98.0) 70 (58.8) 753 (85.5)
  Community health center 66 (11.7) 3 (1.5) 36 (30.3) 105 (11.9)
  Hospital-based clinic 9 (1.6) 1 (0.5) 13 (10.9) 23 (2.6)
Years in practice as a civil surgeonb 10 [4–18] 12 [5–20] 9 [4–12] 10 [4–19]
SA evaluations in past 30 daysb 5 [2–10] 9 [4–15] 8 [1–10] 5 [2–10]
Attended medical school in the U. S. 265 (46.5) 100 (49.8) 83 (71.6) 448 (50.5)
Received training in a primary care fieldc 554 (95.5) 191 (94.6) 112 (93.3) 857 (95.0)
Read technical instructions 484 (84.5) 156 (78.8) 99 (84.6) 739 (83.2)
Missing responses were excluded for all rows
SA status adjustors
a




Internal medicine, family medicine, general medicine, pediatrics, and obstetrics or gynecology
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Table 2
Screening and follow-up practices of civil surgeons in California, Texas, and New England, 2011–2012
Characteristica California Texas New England Total
Screening test usedb
  Tuberculin skin test 554 (96.2) 197 (98.5) 116 (98.3) 867 (97.0)
  Interferon-gamma release assay 25 (4.3) 1 (0.5) 3 (2.5) 29 (3.2)
  Chest radiograph 6 (1.0) 2 (1.0) 0 (0.0) 8 (0.9)
Testing practice for BCG vaccinatedb
  TST 370 (64.7) 137 (68.8) 88 (74.6) 595 (66.9)
  IGRA 36 (6.3) 9 (4.5) 7 (5.9) 52 (5.9)
  TST or IGRAc 64 (11.2) 14 (7.0) 19 (16.1) 97 (10.9)
  CXR 82 (14.3) 28 (14.1) 3 (2.5) 113 (12.7)
  CXR and TST or IGRA 13 (2.3) 6 (3.0) 1 (0.9) 20 (2.3)
  Do not test 7 (1.2) 5 (2.5) 0 (0.0) 12 (1.4)
CXR required for TST result on examd
  ≥5 mm for all SA 346 (63.7) 130 (65.3) – 476 (64.2)
  ≥5 mm for immunosuppressed; ≥10 mm for all others 159 (29.2) 46 (23.1) – 205 (27.6)
  ≥10 mm for everyone 38 (7.0) 23 (11.6) – 61 (8.2)
Responded correctly to a case scenario 458 (78.7) 167 (83.9) 98 (83.1) 723 (80.4)
SA referred for CXRe
  Positive TST or IGRA result 575 (99.3) 194 (97.0) 120 (100) 889 (98.9)
  Symptoms suggestive of TB 351 (60.6) 130 (65.0) 84 (70.0) 565 (62.9)
  Immunosuppressed 193 (33.3) 82 (41.0) 51 (42.5) 326 (36.3)
BCG Bacille Calmette-Guerin, CXR chest radiograph, HIV human immunodeficiency virus, IGRA interferon-gamma release assay, SA status 
adjustor, TST tuberculin skin test, TB tuberculosis
a
Values expressed as n (%)
b
Correct response: either TST or IGRA; IGRA preferred in persons who had BCG vaccination
c
Includes CS who use both TST and IGRA for each patient and CS who use TST or IGRA on patient-by-patient basis
d
Correct response: ≥5 mm for all SA. Question was not asked of New England respondents
e
Correct response: all answers (positive test result, symptomatic, immunosuppressed)
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Table 3
Civil surgeons’ responses to suspected TB disease or LTBI, California, Texas, and New England, 2011–2012
Characteristica California Texas New England Total
Next step for suspected TB diseaseb
  Report case or refer SA to health dept. 513 (90.3) 167 (87.0) 95 (79.2) 775 (88.1)
  Refer the patient to a specialist 239 (42.1) 78 (40.6) 77 (64.2) 394 (44.8)
  Send sputum for AFB smear and culture 207 (36.4) 39 (20.3) 37 (30.8) 283 (32.2)
  Start treatment immediately 118 (20.8) 17 (8.9) 8 (6.7) 143 (16.3)
Correct response to a case scenario about a positive TST and abnormal CXRc 260 (45.2) 99 (49.3) – 359 (46.3)
Next step after diagnosis of LTBI
  Do not start or refer for treatment 60 (10.5) 21 (10.5) 10 (8.3) 91 (10.2)
  Refer for treatment only 251 (44.0) 145 (72.1) 83 (69.2) 479 (53.7)
  Start treatment or refer for treatment 159 (27.9) 26 (12.9) 9 (7.5) 194 (21.8)
  Start treatment only 101 (17.7) 9 (4.5) 18 (15.0) 128 (14.4)
AFB acid fast bacilli, CXR chest radiograph, LTBI latent tuberculosis infection, SA status adjustor, TST tuberculin skin test, TB tuberculosis
a
Values expressed as n (%)
b
Respondents could select more than one answer
c
Question was not asked of New England respondents
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